Earum Pharmaceuticals Ltd.
Snapshot View

2.75 -0.08 ▼-2.8%

03 October 2022, 01:06:00 PM
Volume: 504,303

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.earumpharma.com
Market Cap 17.02 Cr.
Enterprise Value(EV) 26.33 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 0.97 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 2.84 Trailing Twelve Months Ending 2022-06
Industry PE 31.52 Trailing Twelve Months Ending 2022-06
Book Value / Share 2.77 Trailing Twelve Months Ending 2022-06
Price to Book Value 1.00 Calculated using Price: 2.76
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 6.17 Cr. 61,679,100 Shares
FaceValue 2
Company Profile
The company is engaged in the pharmaceutical business involving marketing, trading and distribution of wide range of pharmaceutical formulation products such as anti-biotic drugs, anti-malarial drugs, anti-allergic & anti cold drugs, analgesic/ anti-pyretic & anti inflammatory drugs, dermatology products, cerebral activator drugs, neurological drugs, gastro intestinal drugs, steroids, gynecology drugs, calcium, multivitamins, anti-oxidants and injections. Apart from pharmaceutical formulation products, it also deals in trading of active pharmaceutical ingredients (API's) such as Levofloxacin Hemihdrate IP, Albendazol IP, Amoxicillin Trihydrate IP etc.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-2.83%
1 Week
+4.17%
1 Month
+18.53%
3 Month
-14.33%
6 Month
-51.67%
1 Year
-87.11%
2 Year
-61.65%
5 Year
10 Year
7 years 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 7.15 11.05 30.94 32.17 17.83 0.61 14.24
Return on Capital Employed (%) 17.10 21.97 24.94 23.99 17.40 4.23 12.34
Return on Assets (%) 1.11 1.61 5.98 7.77 6.11 0.28 7.85

Balance Sheet View Details >>

Particulars 7 years 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds 1 2 5 6 14 15 17
Non Curr. Liab. 0 1 2 3 1 2 0
Curr. Liab. 7 9 13 15 20 11 12
Minority Int.
Equity & Liab. 9 11 20 23 36 28 29
Non Curr. Assets 0 0 0 0 4 1 1
Curr. Assets 9 11 19 23 32 27 28
Misc. Exp. not W/O
Total Assets 9 11 20 23 36 28 29

Profit Loss View Details >>

Particulars 8 years 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 19 23 35 51 55 41 21 22
Other Income 0 0 0 0 2 9 8 8
Total Income 19 24 36 51 57 50 29 31
Total Expenditure -18 -23 -34 -47 -54 -49 -25 -24
PBIDT 1 1 2 3 4 1 3 7
Interest 0 -1 -1 -1 -1 -1 0 0
Depreciation 0 0 0 0 0 0 0 0
Taxation 0 0 0 -1 -1 0 -1 -1
Exceptional Items
PAT 0 0 1 2 2 0 2 6
Adjusted EPS 1 3 5 0 0 0 1

Cash Flow View Details >>

Particulars 7 years 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 0 0 -7 0 -3 -7 3
Cash Fr. Inv. 0 0 0 0 -3 3 0
Cash Fr. Finan. 1 0 7 1 7 3 -3
Net Change 0 0 0 0 0 -1 0
Cash & Cash Eqvt 0 0 0 0 0 -1 -1

Shareholding Pattern View Details >>

9 Qtrs 2019-09 (%) 2020-03 (%) 2020-09 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 70.04 70.04 70.04 70.04 70.04 70.04 70.04 50.21 37.57
Public 29.96 29.96 29.96 29.96 29.96 29.96 29.96 49.79 62.43
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 30 Sep 2022
Closure of Trading Window
Pursuant to Clause 4 of Schedule B of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015 as amended from time to time and Companys Code of Internal Procedures and Conduct for Prevention of Insider Trading in Securities this is to inform that the trading window for dealing in Equity Shares of the Company by the Insiders will be closed from Saturday 1st October 2022 till 48 hours after the declaration and publication of Unaudited Financial Results for the for the Quarter and half year ended on 30th September 2022. Please take note of the same and oblige.
Thu, 08 Sep 2022
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Payal B Patel
Wed, 07 Sep 2022
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Bhumishth N Patel

Technical Scans View Details >>

Fri, 30 Sep 2022
High Delivery Percentage High Delivery Percentage
Closing Above Previous High Closing Above Previous High
High Increase 1 Month High Increase 1 Month
High Decrease 3 Months High Decrease 3 Months
High Decrease 6 Months High Decrease 6 Months

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 227,696.89 960.45 +1.2%
Divi's Laboratories Ltd. 97,811.90 3,791.00 +2.3%
Cipla Ltd. 89,996.82 1,142.95 +2.5%
Dr. Reddy's Laboratories Ltd. 72,145.56 4,410.50 +1.7%
Apollo Hospitals Enterprise Ltd. 62,833.90 4,424.95 +1.0%
Torrent Pharmaceuticals Ltd. 52,506.43 1,587.65 +1.8%
Abbott India Ltd. 40,438.70 18,878.50 -1.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 58.54 960.45 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-06 31.50 3,791.00 +2.3%
Cipla Ltd. Consolidated 2022-06 36.17 1,142.95 +2.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 24.12 4,410.50 +1.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 71.12 4,424.95 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 65.55 1,587.65 +1.8%
Abbott India Ltd. Standalone 2022-06 50.01 18,878.50 -1.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.54 960.45 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-06 7.87 3,791.00 +2.3%
Cipla Ltd. Consolidated 2022-06 4.19 1,142.95 +2.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.56 4,410.50 +1.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.57 4,424.95 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.21 1,587.65 +1.8%
Abbott India Ltd. Standalone 2022-06 13.56 18,878.50 -1.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 960.45 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,791.00 +2.3%
Cipla Ltd. Consolidated 2022-03 0.04 1,142.95 +2.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,410.50 +1.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,424.95 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,587.65 +1.8%
Abbott India Ltd. Standalone 2022-03 0.00 18,878.50 -1.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 960.45 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,791.00 +2.3%
Cipla Ltd. Consolidated 2022-03 13.10 1,142.95 +2.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,410.50 +1.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,424.95 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,587.65 +1.8%
Abbott India Ltd. Standalone 2022-03 29.95 18,878.50 -1.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 960.45 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,791.00 +2.3%
Cipla Ltd. Consolidated 2022-03 13.10 1,142.95 +2.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,410.50 +1.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,424.95 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,587.65 +1.8%
Abbott India Ltd. Standalone 2022-03 29.95 18,878.50 -1.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 960.45 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,791.00 +2.3%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,142.95 +2.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,410.50 +1.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,424.95 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,587.65 +1.8%
Abbott India Ltd. Standalone 2022-03 4,919.27 18,878.50 -1.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 960.45 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,791.00 +2.3%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,142.95 +2.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,410.50 +1.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,424.95 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,587.65 +1.8%
Abbott India Ltd. Standalone 2022-03 798.70 18,878.50 -1.4%

FAQ's On Earum Pharmaceuticals Ltd.

What is Earum Pharmaceutical share price?

Can I buy Earum Pharmaceutical shares now?

What is the Market Cap of Earum Pharmaceutical?

What are the key metrics to analyse Earum Pharmaceutical?

What is the 52 Week High and Low of Earum Pharmaceutical?

What is the trend of Earum Pharmaceutical share price?